RESEARCH-USE BIOSIMILAR ANTIBODY
Ozekibart
Monoclonal antibody · IgG1
Ozekibart (INBRX-109) is a DR5 agonist and antitumor agent with a human DR5 IC50 of 0.17 nmol/L and human DR5 Ka of 0.11 nmol/L. Ozekibart can be used for the research of unresectable/metastatic chondrosarcoma.
TARGETTNFRSF10B
YMonoclonal antibody
CATALOGSC-BS-302
CATALOG NUMBERSC-BS-302
MOLECULAR WEIGHTApprox. 105.46 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Ozekibart (INBRX-109) is a DR5 agonist and antitumor agent with a human DR5 IC50 of 0.17 nmol/L and human DR5 Ka of 0.11 nmol/L. Ozekibart can be used for the research of unresectable/metastatic chondrosarcoma.
Ozekibart is a recombinant research-use antibody directed against TNFRSF10B.